Document is current

Article History

Received: 3 October 2024

Accepted: 17 January 2025

First Online: 22 January 2025

Declarations

:

: This clinical trial was conducted in full compliance with the ethical principles outlined in the Declaration of Helsinki, as adopted by the World Medical Association (WMA). These principles are dedicated to safeguarding the rights, well-being, and safety of all research participants. All aspects of this study, including its design, implementation, and reporting, will adhere to the latest revision of the Declaration of Helsinki. This includes the requirement for informed consent, ensuring that participants are fully informed about the study’s purpose, procedures, risks, and benefits. Special attention will be given to protecting vulnerable populations, and measures will be taken to minimize potential harm while maximizing the anticipated benefits of the research. This study also complies with all relevant national and local regulations, as well as institutional policies governing research ethics. The study protocol has been reviewed and approved by an independent ethics committee or institutional review committee (IRC).

: The study has been approved by the Institutional Review committee (IRC), Islamic International Medical College (IIMC), Riphah International University. (Ref: Riphah/IIMC/IRC/22/2079).

: Prof. Dr. Maqsood ul Hassan, Prof. Dr. Muhammad Ayaz Bhatti, Prof. Dr. Shabana Ali, Prof. Dr. Shazia Qayyum, and Prof. Dr. Amena Rahim.

: All participants in the clinical trial agreed to take part in this research. They were ensured that their name will not be disclosed anywhere for confidentiality, although their medical record can be used in future research.

: The authors give their consent for the publication of identifiable details to be published in the journal and article.

: The authors declare no competing interests.